FDA Authorizes Antibody Cocktail as COVID-19 Prevention Treatment
sailor(Ocean & Mountain)
The Food and Drug Administration (FDA) has authorized a monoclonal antibody cocktail as a measure to prevent infection in some groups of people who were exposed to the CCP virus, the pathogen that causes COVID-19.
